Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 850 of 991 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/03/14
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 06/30/19
Due: 06/30/20
Phase: N/A
Priority: Normal
Start: 12/12/12
End: 07/08/14
Due: 07/08/15
Phase: N/A
Priority: Normal
Start: 03/28/20
End: 02/12/21
Due: 02/12/22
Phase: N/A
Priority: Normal
Start: 04/16/19
End: 09/30/20
Due: 09/30/21
Phase: N/A
Priority: Normal
Start: 09/03/19
End: 01/31/21
Due: 01/31/22
Phase: N/A
Priority: Normal
Start: 02/01/20
End: 09/30/20
Due: 09/30/21
Phase: N/A
Priority: Normal
Start: 07/19/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 04/30/11
End: 03/31/13
Due: 03/31/14
Phase: N/A
Priority: Normal
Start: 07/31/12
End: 07/31/14
Due: 07/31/15
Phase: N/A
Priority: Normal
Start: 04/15/22
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 10/31/10
End: 05/31/11
Due: 05/31/12
Phase: N/A
Priority: Normal
Start: 02/01/22
End: 11/01/22
Due: 11/01/23
Phase: N/A
Priority: Normal
Start: 05/22/15
End: 07/31/21
Due: 07/31/22
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 06/30/17
Due: 06/30/18
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 04/05/22
Due: 04/05/23
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 03/31/17
Due: 03/31/18
Phase: N/A
Priority: Normal
Start: 01/31/09
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 06/13/22
End: 01/12/24
Due: 01/12/25
Phase: N/A
Priority: Normal
Start: 08/01/22
End: 07/31/25
Due: 07/31/26
Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients
Phase: N/A
Priority: Normal
Start: 05/03/23
End: 10/30/27
Due: 10/30/28
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 04/30/22
Due: 04/30/23
Phase: N/A
Priority: Normal
Start: 07/01/17
End: 02/17/19
Due: 02/17/20
Phase: N/A
Priority: Normal
Start: 05/01/21
End: 02/29/24
Due: 02/28/25
Phase: N/A
Priority: Normal
Start: 11/30/15
End: 12/31/17
Due: 12/31/18